Article
Thrombin-induced platelet-fibrin clot strength: relation to high on-clopidogrel platelet reactivity, genotype, and post-percutaneous coronary intervention outcomes.
Thrombosis and haemostasis - 1 Apr 2014
Jeong Young-Hoon, Bliden Kevin P, Shuldiner Alan R, Tantry Udaya S, Gurbel Paul A
Abstract excerpt
The relationship between thrombin-induced platelet-fibrin clot strength (MATHROMBIN), genotype and high on-treatment platelet reactivity (HPR) is unknown. The aim of this study is to assess the influence of MATHROMBIN measured by thrombelastography on HPR and long-term major adverse cardiovascular events (MACE) in percutaneous coronary intervention (PCI)-treated patients during aspirin and clopidogrel therapy....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.